PSMD14 and ovarian carcinoma: To investigate the therapeutic effect of PSMD14 inhibition on ovarian cancer, we next treated A2780, OVCAR‐3, and HO‐8910 cells with a reported PSMD14 inhibiter named O‐phenanthroline (OPA) [12].